HomeCancerProstate

Prostate

Skilled discusses trial evaluating evaluating relugolix and enzalutamide in high-risk prostate most cancers

On this video, Kelly L. Stratton, MD, FACS, additional discusses a section 1B trial evaluating relugolix (Orgovyx) and enzalutamide (Xtandi) for high-risk prostate...

2024 NCCN Pointers Replace: Metastatic Castration-Resistant Prostate Most cancers Remedy

Learn the Full Video TranscriptRashid Sayyid: Hey, everybody. And thanks for becoming a member of us in the present day on this particular...

Element of keto food regimen plus immunotherapy might cut back prostate most cancers | Information | Notre Dame Information

Including a pre-ketone complement — a part of a high-fat, low-carb ketogenic food...

Hot Topics